Do you want to take your support of a specific cancer research area to the next level while honoring or remembering a family member or loved one? NFCR has the solution for you: Create Your Own Research Fund. NFCR has been setting up designated and restricted fund programs for more than 40 years. These funds allow you to fund a specific researcher, project, cancer type or cancer research area in a significant fashion over a three year+ timeframe that will accelerate the pace of discovery. The fund can be named by you to highlight your cause or as a tribute to your family or loved one to keep that legacy at the forefront of the Research to find a Cure.
Creating Your Own Research Fund allows you to:
- Restrict your support to a specific researcher, project or cancer area;
- Name the fund – many honor the area of research or family and loved ones;
- Meet the principal investigator (lead researcher) of the project you support at least annually;
- Receive research update reports from the principal investigator as NFCR receives them;
- Attend NFCR’s annual Szent-Györgyi Prize for Progress in Cancer Research as a VIP;
- Attend NFCR’s annual Scientific Symposium where all researchers present progress in their projects and researchers; and
- Strengthen your fund by engaging family, colleagues and peers to lead events and other activities in support of your cause. NFCR can help you with ideas on ways to engage others in support of your fund.
How it Works
- Commit to a minimum of 3 years of research support. The amount of your annual gift or size of the fund is dictated by your desired scope of research work. NFCR has helped establish funds that have ranged from $75,000 to $2 million+. Funds can be established and supported by a variety of assets, as well as set up via a gift in a will or estate plan.
- Choose a specific researcher, project, cancer type or area you’d like your fund to be restricted. NFCR can assist in supporting a new project by pre-screening proposals in a field of cancer research you’re interested and arrange presentations on research proposals by the principal investigators for you to consider.
- Choose a name for your fund. If you would like to publicize the fund, NFCR will work with you to build a logo and highlight it on the NFCR.org website, our Annual Report and other marketing avenues.
If you would like to learn more about Creating Your Own Fund, contact:
Assistant Director of Development
301-654-1250 or email at firstname.lastname@example.org
Examples of Named Research Funds at NFCR
Even though over 90% of cancer mortalities are due to metastatic cancer — cancer that spreads from its original location to vital organs within the body — less than 5% of current cancer funding supports research geared towards understanding the mechanisms of metastasis. The Lucy Fund was created to lessen this statistical discrepancy, with hopes that one day researchers will find a way to make cancer a chronic, not deadly, disease.
The Hope Fund for Sarcoma Research is a designated fund established by Ken and Marianne Bouldin in partnership with NFCR. The Bouldins founded the Hope Fund after their daughter Jennifer survived a type of sarcoma known as malignant peripheral nerve sheath tumor (MPNST).
Want to consider establishing a named fund without a long-term commitment?
Consider NFCR’s Rose Fund.
You could also set up a fundraiser through our Rose Fund program in the name of the person you would like to honor or remember. As well as honoring their life, it will also contribute to further advances in cancer research. A Rose Fund can be established with any amount you would like to start a fund with. It also provides you with the flexibility to give whenever you would like to. There are no minimums or monthly requirements to donate to a fund. Anybody can donate or raise money for the Rose Fund now and as far into the future as they wish. We make sure that all donors who choose to be kept informed know how much has been raised for the Fund. We use the money you raise on fulfilling our mission to find better treatments and cures for cancer.